Identification |
Name: | 1H-Indole-2-carboxylicacid, 4,6-dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propen-1-yl]- |
Synonyms: | 1H-Indole-2-carboxylicacid, 4,6-dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propenyl]- (9CI);1H-Indole-2-carboxylic acid,4,6-dichloro-3-[3-oxo-3-(phenylamino)-1-propenyl]-, (E)-; GV 150526; GV150526X; Gavestinel |
CAS: | 153436-22-7 |
Molecular Formula: | C18H12 Cl2 N2 O3 |
Molecular Weight: | 375.21 |
InChI: | InChI=1/C18H12Cl2N2O3.Na/c19-10-8-13(20)16-12(17(18(24)25)22-14(16)9-10)6-7-15(23)21-11-4-2-1-3-5-11;/h1-9,22H,(H,21,23)(H,24,25);/q;+1/p-1/b7-6+; |
Molecular Structure: |
|
Properties |
Flash Point: | 377.8°C |
Boiling Point: | 701.1°Cat760mmHg |
Density: | 1.561g/cm3 |
Biological Activity: | Highly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (K d = 0.8 nM). Displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites. Orally bioavailable and active in vivo . |
Flash Point: | 377.8°C |
Safety Data |
Hazard Symbols |
|
|
|